Living with gMG: Navigating Personal, Professional, and Mental Health Challenges
Vera Bril, MD
Nicholas J. Silvestri, MD
Treatment Advances in Generalized Myasthenia Gravis: Clinical and Laboratory Criteria for Diagnosis and Optimal Treatment Selection
Jonathan Strober, MD
Diagnostic Advances in gMG: Effective Tools and Techniques
Hans Katzberg, MD
Preventing Myasthenic Crisis: Early Signs and Critical Interventions
Treatment Advances in Generalized Myasthenia Gravis: Addressing the Nuances of its Underlying Immunopathology
New Frontiers in MG: How FcRn Antagonists Are Changing MG Therapy
Driving Progress in Cardiology: Exploring the Role of FXI in Acute Coronary Syndromes & Beyond
May 01, 2025
Washington, DC, District of Columbia
Collaborative Insights to Solve the Puzzle of Bladder Cancer
Daniel P. Petrylak, MD
Elizabeth R. Plimack, MD, MS, FASCO
Evan Y. Yu, MD
Personalizing Care Within the RCC Treatment Paradigm
Eric Jonasch, MD
Brad McGregor, MD
Ulka Vaishampayan, MBBS
What’s New in Schlemm’s Canal MIGS?
Paul Petrakos, DO, MS
I. Paul Singh, MD
What’s New in Suprachoroidal MIGS?
What’s New in Glaucoma Therapy?
Justin Schweitzer, OD, FAAO
Sarah H. Van Tassel, MD
3D Heads-Up Visualization: Cases in Glaucoma Surgery
World Obesity Day: Call to Action
Donna Ryan, MD
Ricardo Cohen, MD, PhD
Recent Updates on Ovarian Function Suppression in Premenopausal HR+ Early-Stage Breast Cancer
Sandra Swain, MD
Virginia Kaklamani, MD
Duration of Ovarian Function Suppression in Premenopausal HR+ Early-Stage Breast Cancer
Loading...
We're glad to see you're enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.